The competent cells market is projected to grow from USD 2.9 billion in 2025 to USD 8.3 billion by 2035, at a CAGR of 11.1%. Chemically Competent Cells will dominate with a 61.0% market share, while cloning will lead the application type segment with a 47.0% share.